A prominent feature of B-CLL cells is the strong correlation of UGT2B17 expression with the adverse marker ZAP70 encoding a tyrosine kinase that promotes B-CLL cell survival. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.